Liao BC, Chih-Hsin Yang J. Active or Attractive? Oral Antiangiogenesis Therapy Plus EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant NSCLC. J Thorac Oncol 2021;16:1426-1428.
PMID: 34425993